Immune cell balance as potential biomarker of progressing non-alcoholic fatty liver disease
Article in Genes and Cells (March 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway.
Article in European Journal of Pharmacology (November 2023)